Publikationen 2004:

Rott H, Halimeh S, Trobisch H, Kappert G, Ivaskevicius V:
"Two patients with recurrent abortions and the same novel mutation in the fibrinogen gamma chain (FGG)."
Hämophilie-Symposion Hamburg November 2004.

Rott H, Halimeh S, Trobisch H:
"Comparison of two quantitative D-dimer assays in outpatients."
Kongress für klinische Chemie und Laboratoriumsmedizin, 2004, Düsseldorf.

Rott H, Halimeh S, Trobisch H:
"Successfull treatment with a factor XIII-concentrate (Fibrogammin) in pregnancy in a patient with a novel factor-XIII-B-Gene-Mutation."
Congress World Federation of haemophilia (WFH) 2004 Bangkok, Thailand.

Rott H, Trobisch H, Kretzschmar E:
"Use of recombinant factor VIIa, NovoSeven, in the management of acute haemorrhage."
Curr Opin Anaesthesiol 2004 Apr;17(2):159-63.

Christensen MO, Krokowski M, Barthelmes HU, et al.
"Distinct Effects of Topoisomerase I and RNA Polymerase I Inhibitors Suggest a Dual Mechanism of Nucleolar / Nucleoplasmic Partitioning of Topoisomerase I". 
Biochemistry. 2004;279(21):21873-21882.

Barthelmes HU, Habermeyer M, Christensen MO, et al.
"TDP1 Overexpression in Human Cells Counteracts DNA Damage Mediated by Topoisomerases I and II." 
October. 2004;279(53):55618 -55625.

Chaitanya A. Athale, Morten O. Christensen, Roland Eils, Fritz Boege, Christian Mielke:
"Inferring a System Model of Subcellular Topoisomerase IIbeta Localization Dynamics.
Journal of Integrative Biology 2004 (8),2:167ff.

Mielke C, Christensen MO, Barthelmes HU, Boege F.
"Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells." 
The Journal of biological chemistry. 2004;279(20):20559-62.